 Peter Dempsey
Concepts (681)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| ADAM Proteins | 26 | 2015 | 61 | 2.960 |
Why?
| | Amyloid Precursor Protein Secretases | 13 | 2021 | 80 | 2.120 |
Why?
| | Intestines | 8 | 2025 | 357 | 1.720 |
Why?
| | Membrane Proteins | 20 | 2022 | 1164 | 1.630 |
Why?
| | Cell Plasticity | 3 | 2025 | 35 | 1.510 |
Why?
| | ADAM10 Protein | 15 | 2022 | 30 | 1.370 |
Why?
| | Stem Cell Niche | 3 | 2021 | 54 | 1.300 |
Why?
| | ErbB Receptors | 28 | 2018 | 614 | 1.280 |
Why?
| | Transforming Growth Factor alpha | 25 | 2013 | 57 | 1.270 |
Why?
| | Intercellular Signaling Peptides and Proteins | 15 | 2013 | 382 | 1.230 |
Why?
| | Metalloendopeptidases | 14 | 2017 | 62 | 1.190 |
Why?
| | Receptors, Notch | 3 | 2020 | 88 | 1.150 |
Why?
| | Organoids | 10 | 2025 | 112 | 1.080 |
Why?
| | Protein Precursors | 8 | 2010 | 134 | 1.080 |
Why?
| | Breast Neoplasms | 27 | 2014 | 2253 | 1.040 |
Why?
| | Ultrasonography, Mammary | 8 | 2010 | 13 | 0.940 |
Why?
| | Integrases | 2 | 2018 | 120 | 0.880 |
Why?
| | Intestinal Mucosa | 9 | 2025 | 623 | 0.860 |
Why?
| | Mammography | 17 | 2010 | 154 | 0.800 |
Why?
| | Breast | 11 | 2010 | 151 | 0.760 |
Why?
| | Paneth Cells | 3 | 2018 | 16 | 0.740 |
Why?
| | Biopsy, Needle | 8 | 2010 | 189 | 0.710 |
Why?
| | ADAM17 Protein | 18 | 2022 | 35 | 0.660 |
Why?
| | Intestinal Neoplasms | 2 | 2018 | 29 | 0.640 |
Why?
| | Regeneration | 4 | 2025 | 197 | 0.630 |
Why?
| | Pulmonary Embolism | 1 | 2022 | 226 | 0.620 |
Why?
| | alpha-Defensins | 1 | 2018 | 10 | 0.610 |
Why?
| | Parenteral Nutrition, Total | 2 | 2015 | 26 | 0.600 |
Why?
| | Cell Membrane | 10 | 2017 | 738 | 0.580 |
Why?
| | Signal Transduction | 25 | 2018 | 5079 | 0.570 |
Why?
| | Epidermal Growth Factor | 13 | 2015 | 177 | 0.530 |
Why?
| | Proteolysis | 1 | 2017 | 177 | 0.520 |
Why?
| | Carcinogenesis | 2 | 2018 | 217 | 0.510 |
Why?
| | Animals | 73 | 2025 | 36940 | 0.480 |
Why?
| | Breast Diseases | 4 | 2010 | 22 | 0.480 |
Why?
| | Mice | 47 | 2025 | 17787 | 0.470 |
Why?
| | Growth Substances | 8 | 2001 | 147 | 0.460 |
Why?
| | Epithelial Cells | 12 | 2025 | 1096 | 0.460 |
Why?
| | Neuroendocrine Tumors | 1 | 2016 | 116 | 0.450 |
Why?
| | Carcinoma, Lobular | 4 | 2014 | 49 | 0.420 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2015 | 1242 | 0.410 |
Why?
| | Metalloproteases | 6 | 2017 | 43 | 0.410 |
Why?
| | Gastrointestinal Tract | 1 | 2015 | 195 | 0.410 |
Why?
| | Glycoproteins | 9 | 2008 | 342 | 0.400 |
Why?
| | Radiographic Image Enhancement | 3 | 2008 | 58 | 0.400 |
Why?
| | Cell Line | 20 | 2014 | 2847 | 0.390 |
Why?
| | Cell Proliferation | 11 | 2024 | 2475 | 0.370 |
Why?
| | Stem Cells | 3 | 2020 | 594 | 0.370 |
Why?
| | Protein Processing, Post-Translational | 8 | 2007 | 465 | 0.370 |
Why?
| | Neoplasms | 6 | 2017 | 2671 | 0.360 |
Why?
| | Radiology | 1 | 2014 | 180 | 0.360 |
Why?
| | Gene Targeting | 1 | 2010 | 81 | 0.340 |
Why?
| | Emergency Service, Hospital | 1 | 2022 | 2069 | 0.330 |
Why?
| | Intestine, Small | 3 | 2025 | 156 | 0.330 |
Why?
| | Tamoxifen | 1 | 2010 | 202 | 0.320 |
Why?
| | Unnecessary Procedures | 1 | 2010 | 50 | 0.320 |
Why?
| | Mice, Knockout | 12 | 2015 | 3015 | 0.310 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2024 | 289 | 0.310 |
Why?
| | Mass Screening | 5 | 2009 | 1287 | 0.300 |
Why?
| | Cell Polarity | 6 | 2003 | 141 | 0.300 |
Why?
| | Radiographic Magnification | 1 | 2008 | 1 | 0.290 |
Why?
| | Terminology as Topic | 2 | 2007 | 216 | 0.290 |
Why?
| | Stomach | 3 | 2009 | 110 | 0.290 |
Why?
| | Inflammation | 5 | 2019 | 2837 | 0.290 |
Why?
| | Muscle, Smooth, Vascular | 7 | 2008 | 446 | 0.280 |
Why?
| | Thinness | 1 | 2008 | 91 | 0.280 |
Why?
| | Cell Lineage | 3 | 2025 | 350 | 0.280 |
Why?
| | Hydrogels | 3 | 2025 | 678 | 0.270 |
Why?
| | Humans | 86 | 2024 | 137585 | 0.270 |
Why?
| | Apoptosis | 10 | 2021 | 2553 | 0.270 |
Why?
| | Peptide Fragments | 2 | 2010 | 706 | 0.260 |
Why?
| | Hyperplasia | 3 | 2018 | 175 | 0.250 |
Why?
| | Homeostasis | 2 | 2021 | 621 | 0.250 |
Why?
| | Phenylmercuric Acetate | 2 | 2008 | 2 | 0.250 |
Why?
| | Insulin-Secreting Cells | 1 | 2010 | 377 | 0.240 |
Why?
| | Transcriptional Activation | 6 | 2013 | 378 | 0.240 |
Why?
| | Amino Acid Sequence | 12 | 2017 | 2139 | 0.230 |
Why?
| | Cell Differentiation | 8 | 2025 | 1991 | 0.230 |
Why?
| | Drug Delivery Systems | 1 | 2008 | 365 | 0.220 |
Why?
| | Pancreatic Neoplasms | 2 | 2024 | 938 | 0.220 |
Why?
| | Dogs | 8 | 2011 | 413 | 0.220 |
Why?
| | Angiotensin II | 4 | 2008 | 99 | 0.220 |
Why?
| | Allyl Compounds | 2 | 2022 | 21 | 0.210 |
Why?
| | Protein Structure, Tertiary | 8 | 2010 | 861 | 0.210 |
Why?
| | Mice, Inbred C57BL | 13 | 2025 | 5757 | 0.200 |
Why?
| | Sulfides | 2 | 2022 | 99 | 0.200 |
Why?
| | beta Catenin | 2 | 2023 | 253 | 0.200 |
Why?
| | Molecular Sequence Data | 11 | 2011 | 2900 | 0.190 |
Why?
| | Energy Metabolism | 1 | 2008 | 922 | 0.190 |
Why?
| | Betacellulin | 5 | 2010 | 6 | 0.190 |
Why?
| | Mice, Transgenic | 11 | 2020 | 2167 | 0.190 |
Why?
| | Enzyme Inhibitors | 6 | 2008 | 840 | 0.180 |
Why?
| | Radiologists | 1 | 2022 | 51 | 0.180 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 111 | 0.180 |
Why?
| | Calcium | 5 | 2010 | 1199 | 0.180 |
Why?
| | Chest Pain | 1 | 2022 | 91 | 0.180 |
Why?
| | Ultrasonography | 8 | 2009 | 759 | 0.170 |
Why?
| | Gamma Rays | 1 | 2021 | 57 | 0.170 |
Why?
| | Microscopy | 1 | 2022 | 152 | 0.170 |
Why?
| | Cell Movement | 5 | 2021 | 967 | 0.170 |
Why?
| | Antibodies, Monoclonal | 8 | 2000 | 1430 | 0.170 |
Why?
| | Receptor, ErbB-4 | 3 | 2017 | 19 | 0.170 |
Why?
| | Taste Buds | 1 | 2023 | 208 | 0.170 |
Why?
| | Immunohistochemistry | 6 | 2010 | 1738 | 0.160 |
Why?
| | Photolysis | 1 | 2020 | 91 | 0.160 |
Why?
| | Female | 40 | 2021 | 73304 | 0.160 |
Why?
| | Antiporters | 1 | 2019 | 22 | 0.160 |
Why?
| | Radiation Injuries | 1 | 2021 | 145 | 0.160 |
Why?
| | Doxorubicin | 3 | 2018 | 362 | 0.160 |
Why?
| | Gastric Mucosa | 7 | 2009 | 55 | 0.160 |
Why?
| | Cell Survival | 2 | 2014 | 1120 | 0.160 |
Why?
| | Colitis | 2 | 2019 | 266 | 0.160 |
Why?
| | Histones | 1 | 2025 | 636 | 0.160 |
Why?
| | History, 21st Century | 2 | 2014 | 213 | 0.150 |
Why?
| | Cells, Cultured | 17 | 2019 | 4193 | 0.150 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2021 | 209 | 0.150 |
Why?
| | Gene Deletion | 2 | 2018 | 391 | 0.150 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2018 | 20 | 0.150 |
Why?
| | Cell Dedifferentiation | 1 | 2018 | 32 | 0.150 |
Why?
| | Multipotent Stem Cells | 1 | 2018 | 20 | 0.150 |
Why?
| | Colon | 3 | 2017 | 282 | 0.150 |
Why?
| | T-Lymphocytes | 5 | 2013 | 1996 | 0.150 |
Why?
| | History, 20th Century | 2 | 2014 | 325 | 0.150 |
Why?
| | Acidosis | 1 | 2019 | 101 | 0.150 |
Why?
| | Protease Inhibitors | 4 | 2012 | 107 | 0.150 |
Why?
| | Clone Cells | 1 | 2018 | 265 | 0.140 |
Why?
| | Mitosis | 2 | 2018 | 192 | 0.140 |
Why?
| | Sulfhydryl Compounds | 1 | 2020 | 189 | 0.140 |
Why?
| | Fibrosis | 1 | 2021 | 552 | 0.140 |
Why?
| | Atrophy | 2 | 2015 | 184 | 0.140 |
Why?
| | Ligands | 8 | 2022 | 664 | 0.140 |
Why?
| | Leptin | 2 | 2010 | 236 | 0.140 |
Why?
| | Cysteine Endopeptidases | 1 | 2017 | 73 | 0.140 |
Why?
| | Adhesins, Bacterial | 1 | 2017 | 40 | 0.140 |
Why?
| | EGF Family of Proteins | 7 | 2008 | 17 | 0.140 |
Why?
| | Amphiregulin | 7 | 2008 | 25 | 0.140 |
Why?
| | STAT3 Transcription Factor | 2 | 2018 | 206 | 0.140 |
Why?
| | Goblet Cells | 2 | 2014 | 22 | 0.140 |
Why?
| | Keratinocytes | 6 | 2010 | 249 | 0.130 |
Why?
| | Neutrophils | 3 | 2019 | 1238 | 0.130 |
Why?
| | Antineoplastic Agents | 2 | 2008 | 2129 | 0.130 |
Why?
| | Kidney | 5 | 2001 | 1468 | 0.130 |
Why?
| | Endothelial Cells | 1 | 2022 | 785 | 0.130 |
Why?
| | Adenoma | 1 | 2018 | 230 | 0.130 |
Why?
| | Base Sequence | 6 | 2011 | 2181 | 0.130 |
Why?
| | Cytokines | 2 | 2015 | 2085 | 0.120 |
Why?
| | Gene Expression Regulation | 4 | 2014 | 2607 | 0.120 |
Why?
| | Receptor, ErbB-2 | 3 | 2007 | 341 | 0.120 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2008 | 261 | 0.120 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2013 | 718 | 0.120 |
Why?
| | X-Ray Intensifying Screens | 2 | 2006 | 2 | 0.120 |
Why?
| | Alleles | 1 | 2018 | 891 | 0.120 |
Why?
| | Sensitivity and Specificity | 5 | 2008 | 1946 | 0.120 |
Why?
| | Transfection | 7 | 2006 | 945 | 0.120 |
Why?
| | Magnetic Resonance Imaging | 2 | 2009 | 3566 | 0.120 |
Why?
| | Time Factors | 6 | 2014 | 6828 | 0.120 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 118 | 0.120 |
Why?
| | Receptor, Notch1 | 2 | 2013 | 64 | 0.120 |
Why?
| | Receptor, Notch2 | 2 | 2011 | 15 | 0.110 |
Why?
| | Hydrolysis | 5 | 2010 | 177 | 0.110 |
Why?
| | Amyloid beta-Protein Precursor | 2 | 2012 | 66 | 0.110 |
Why?
| | Enteroendocrine Cells | 1 | 2014 | 6 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 976 | 0.110 |
Why?
| | Kinetics | 5 | 2005 | 1670 | 0.110 |
Why?
| | Lateral Ventricles | 1 | 2014 | 35 | 0.110 |
Why?
| | Phenotype | 4 | 2014 | 3196 | 0.110 |
Why?
| | Solubility | 3 | 2020 | 245 | 0.110 |
Why?
| | B-Lymphocytes | 3 | 2010 | 847 | 0.110 |
Why?
| | Anesthesia, Local | 1 | 1993 | 19 | 0.110 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 1990 | 152 | 0.110 |
Why?
| | ROC Curve | 4 | 2008 | 554 | 0.110 |
Why?
| | Neoplasm Staging | 5 | 2018 | 1389 | 0.100 |
Why?
| | Interleukin-6 | 1 | 2018 | 778 | 0.100 |
Why?
| | Immunoreceptor Tyrosine-Based Activation Motif | 1 | 2013 | 1 | 0.100 |
Why?
| | Cell Division | 8 | 2004 | 794 | 0.100 |
Why?
| | Gastritis, Hypertrophic | 1 | 1992 | 3 | 0.100 |
Why?
| | Probiotics | 1 | 2013 | 54 | 0.100 |
Why?
| | Cell Nucleus | 3 | 2018 | 620 | 0.100 |
Why?
| | Cell Line, Tumor | 6 | 2024 | 3412 | 0.100 |
Why?
| | Tumor Cells, Cultured | 6 | 2021 | 955 | 0.100 |
Why?
| | Diagnosis, Differential | 3 | 2007 | 1483 | 0.100 |
Why?
| | Toll-Like Receptor 4 | 1 | 2015 | 273 | 0.100 |
Why?
| | Cadherins | 1 | 2014 | 206 | 0.100 |
Why?
| | CD3 Complex | 1 | 2013 | 106 | 0.100 |
Why?
| | Blotting, Western | 5 | 2008 | 1226 | 0.100 |
Why?
| | Neural Stem Cells | 1 | 2014 | 156 | 0.100 |
Why?
| | Protein Kinase C | 4 | 2003 | 261 | 0.100 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2017 | 351 | 0.100 |
Why?
| | Skin | 3 | 2010 | 752 | 0.100 |
Why?
| | Protein Kinase C-delta | 3 | 2008 | 48 | 0.090 |
Why?
| | Ultrasonography, Interventional | 3 | 2010 | 141 | 0.090 |
Why?
| | Reproducibility of Results | 5 | 2020 | 3284 | 0.090 |
Why?
| | Genes, ras | 3 | 1998 | 97 | 0.090 |
Why?
| | Cytoplasm | 2 | 2003 | 274 | 0.090 |
Why?
| | Biopsy, Fine-Needle | 2 | 2009 | 68 | 0.090 |
Why?
| | Macrophages | 2 | 2017 | 1547 | 0.090 |
Why?
| | Mice, Mutant Strains | 2 | 2008 | 298 | 0.090 |
Why?
| | Retrospective Studies | 6 | 2022 | 15657 | 0.090 |
Why?
| | Extracellular Matrix | 3 | 2022 | 528 | 0.090 |
Why?
| | Galactosides | 1 | 2010 | 5 | 0.090 |
Why?
| | Presenilin-2 | 1 | 2010 | 5 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2020 | 455 | 0.090 |
Why?
| | Protein Transport | 2 | 2003 | 445 | 0.080 |
Why?
| | Estrogen Antagonists | 1 | 2010 | 45 | 0.080 |
Why?
| | Crosses, Genetic | 1 | 2010 | 137 | 0.080 |
Why?
| | Presenilin-1 | 1 | 2010 | 31 | 0.080 |
Why?
| | Lipoylation | 1 | 2010 | 17 | 0.080 |
Why?
| | Recovery of Function | 1 | 2014 | 653 | 0.080 |
Why?
| | Receptors, IgE | 1 | 2010 | 45 | 0.080 |
Why?
| | Hydrogen Peroxide | 3 | 2006 | 328 | 0.080 |
Why?
| | TRPV Cation Channels | 1 | 2010 | 40 | 0.080 |
Why?
| | Genes, Reporter | 1 | 2010 | 269 | 0.080 |
Why?
| | Hair | 1 | 2010 | 84 | 0.080 |
Why?
| | Peptides | 1 | 1995 | 985 | 0.080 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2024 | 872 | 0.080 |
Why?
| | Paclitaxel | 3 | 2024 | 230 | 0.080 |
Why?
| | Radiography | 3 | 2014 | 822 | 0.080 |
Why?
| | Calcinosis | 2 | 2006 | 235 | 0.080 |
Why?
| | DNA, Complementary | 3 | 2010 | 272 | 0.080 |
Why?
| | Mutagenesis | 2 | 2001 | 179 | 0.080 |
Why?
| | Laminin | 2 | 2025 | 72 | 0.080 |
Why?
| | Antigens, CD | 3 | 2007 | 521 | 0.080 |
Why?
| | Male | 15 | 2017 | 67762 | 0.080 |
Why?
| | Helicobacter Infections | 1 | 2009 | 32 | 0.080 |
Why?
| | Uncoupling Protein 1 | 1 | 2008 | 16 | 0.070 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 2008 | 16 | 0.070 |
Why?
| | Fats | 1 | 2008 | 17 | 0.070 |
Why?
| | Immunoglobulin G | 2 | 2010 | 893 | 0.070 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2018 | 1396 | 0.070 |
Why?
| | Adult | 16 | 2010 | 37929 | 0.070 |
Why?
| | Disintegrins | 2 | 2007 | 5 | 0.070 |
Why?
| | Fluorescent Dyes | 1 | 2010 | 321 | 0.070 |
Why?
| | Lymphocyte Activation | 3 | 2013 | 1142 | 0.070 |
Why?
| | Hydroxamic Acids | 3 | 2006 | 89 | 0.070 |
Why?
| | Swine | 1 | 2010 | 775 | 0.070 |
Why?
| | Ion Channels | 1 | 2008 | 133 | 0.070 |
Why?
| | Enzyme Precursors | 1 | 2007 | 15 | 0.070 |
Why?
| | Isoenzymes | 2 | 2000 | 304 | 0.070 |
Why?
| | HEK293 Cells | 3 | 2017 | 730 | 0.070 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2007 | 39 | 0.070 |
Why?
| | Hypothalamus | 1 | 2008 | 153 | 0.070 |
Why?
| | Intercellular Junctions | 2 | 2000 | 40 | 0.070 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2006 | 220 | 0.070 |
Why?
| | Efficiency | 1 | 2008 | 99 | 0.070 |
Why?
| | Bacterial Proteins | 1 | 2013 | 879 | 0.070 |
Why?
| | Observer Variation | 1 | 2008 | 343 | 0.070 |
Why?
| | Middle Aged | 14 | 2007 | 33479 | 0.070 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2006 | 1692 | 0.070 |
Why?
| | Receptors, Cell Surface | 3 | 2022 | 385 | 0.070 |
Why?
| | Ultrasonography, Doppler | 1 | 2007 | 124 | 0.070 |
Why?
| | Cell Transformation, Neoplastic | 3 | 2000 | 327 | 0.070 |
Why?
| | Adipocytes | 1 | 2008 | 222 | 0.060 |
Why?
| | Heparin-binding EGF-like Growth Factor | 3 | 2013 | 16 | 0.060 |
Why?
| | Disease Models, Animal | 5 | 2019 | 4295 | 0.060 |
Why?
| | Receptor, ErbB-3 | 1 | 2006 | 44 | 0.060 |
Why?
| | Mitochondrial Proteins | 1 | 2008 | 257 | 0.060 |
Why?
| | Phosphorylation | 6 | 2013 | 1759 | 0.060 |
Why?
| | Cell Line, Transformed | 2 | 2004 | 145 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 3 | 2004 | 313 | 0.060 |
Why?
| | Colorectal Neoplasms | 2 | 2018 | 806 | 0.060 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2008 | 267 | 0.060 |
Why?
| | Tyrosine | 3 | 2008 | 222 | 0.060 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2006 | 110 | 0.060 |
Why?
| | Eating | 1 | 2008 | 380 | 0.060 |
Why?
| | Early Detection of Cancer | 1 | 2010 | 447 | 0.060 |
Why?
| | Receptor, Angiotensin, Type 2 | 1 | 2005 | 9 | 0.060 |
Why?
| | Receptors, Progesterone | 1 | 2007 | 350 | 0.060 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2004 | 852 | 0.060 |
Why?
| | United States | 3 | 2014 | 14841 | 0.060 |
Why?
| | Recombinant Proteins | 3 | 2010 | 1353 | 0.060 |
Why?
| | Nucleoside-Phosphate Kinase | 1 | 2005 | 1 | 0.060 |
Why?
| | Neoplasm, Residual | 1 | 2006 | 133 | 0.060 |
Why?
| | Endothelin-1 | 1 | 2006 | 182 | 0.060 |
Why?
| | Colonic Neoplasms | 2 | 1999 | 258 | 0.060 |
Why?
| | Organ Culture Techniques | 3 | 2014 | 156 | 0.060 |
Why?
| | Receptors, Estrogen | 1 | 2007 | 436 | 0.060 |
Why?
| | Rats | 9 | 2008 | 5647 | 0.060 |
Why?
| | Biological Transport | 3 | 2008 | 418 | 0.060 |
Why?
| | RNA, Messenger | 7 | 2018 | 2833 | 0.060 |
Why?
| | Ion Transport | 1 | 2004 | 60 | 0.060 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2006 | 389 | 0.060 |
Why?
| | GTP-Binding Proteins | 1 | 2005 | 161 | 0.060 |
Why?
| | Gastric Acid | 2 | 1995 | 14 | 0.060 |
Why?
| | Physical Examination | 1 | 2006 | 241 | 0.060 |
Why?
| | Methylation | 1 | 2025 | 230 | 0.050 |
Why?
| | Mice, Nude | 2 | 2024 | 698 | 0.050 |
Why?
| | Chemokines, CXC | 1 | 2004 | 70 | 0.050 |
Why?
| | Molecular Weight | 3 | 1997 | 335 | 0.050 |
Why?
| | Enzyme Activation | 4 | 2013 | 810 | 0.050 |
Why?
| | Up-Regulation | 2 | 2019 | 843 | 0.050 |
Why?
| | DNA Primers | 1 | 2004 | 515 | 0.050 |
Why?
| | Leiomyosarcoma | 1 | 2003 | 28 | 0.050 |
Why?
| | Heparin | 1 | 2005 | 261 | 0.050 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2003 | 39 | 0.050 |
Why?
| | Motor Activity | 1 | 2008 | 718 | 0.050 |
Why?
| | Neurons | 1 | 2012 | 1590 | 0.050 |
Why?
| | Receptor Protein-Tyrosine Kinases | 2 | 2003 | 234 | 0.050 |
Why?
| | Mutation | 5 | 2010 | 3958 | 0.050 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2007 | 752 | 0.050 |
Why?
| | Deoxycytidine | 1 | 2024 | 179 | 0.050 |
Why?
| | Mammary Glands, Animal | 2 | 1995 | 129 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2004 | 216 | 0.050 |
Why?
| | Amino Acid Motifs | 1 | 2003 | 225 | 0.050 |
Why?
| | Leucine | 1 | 2003 | 111 | 0.050 |
Why?
| | Tongue | 1 | 2023 | 81 | 0.050 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 2002 | 15 | 0.050 |
Why?
| | Cysts | 2 | 1992 | 113 | 0.050 |
Why?
| | Uterine Neoplasms | 1 | 2003 | 109 | 0.050 |
Why?
| | Immunoenzyme Techniques | 4 | 2003 | 219 | 0.050 |
Why?
| | Wnt Signaling Pathway | 1 | 2024 | 192 | 0.050 |
Why?
| | Epithelium | 3 | 1995 | 313 | 0.050 |
Why?
| | Gene Knockdown Techniques | 2 | 2013 | 327 | 0.050 |
Why?
| | Morphogenesis | 1 | 2023 | 166 | 0.050 |
Why?
| | Dandy-Walker Syndrome | 1 | 1981 | 7 | 0.050 |
Why?
| | Chemokines, CX3C | 1 | 2001 | 10 | 0.050 |
Why?
| | Aged | 8 | 2007 | 23961 | 0.050 |
Why?
| | Hedgehog Proteins | 1 | 2023 | 195 | 0.050 |
Why?
| | Milk Proteins | 2 | 1995 | 34 | 0.050 |
Why?
| | Women's Health | 1 | 2004 | 372 | 0.040 |
Why?
| | Prevalence | 1 | 2008 | 2734 | 0.040 |
Why?
| | Ephrin-B2 | 1 | 2021 | 47 | 0.040 |
Why?
| | Prognosis | 2 | 2021 | 4030 | 0.040 |
Why?
| | Phenylalanine | 2 | 1998 | 68 | 0.040 |
Why?
| | Sequence Deletion | 1 | 2001 | 183 | 0.040 |
Why?
| | Brain | 2 | 2010 | 2668 | 0.040 |
Why?
| | Precipitin Tests | 3 | 2004 | 100 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2005 | 771 | 0.040 |
Why?
| | Retroviridae Proteins, Oncogenic | 1 | 2000 | 11 | 0.040 |
Why?
| | Quinazolines | 2 | 2015 | 251 | 0.040 |
Why?
| | Hydrocephalus | 1 | 1981 | 106 | 0.040 |
Why?
| | Shear Strength | 1 | 2020 | 67 | 0.040 |
Why?
| | Brain Diseases | 1 | 1981 | 141 | 0.040 |
Why?
| | Neovascularization, Pathologic | 1 | 2022 | 301 | 0.040 |
Why?
| | Thiophenes | 2 | 1998 | 117 | 0.040 |
Why?
| | CD40 Antigens | 1 | 2000 | 89 | 0.040 |
Why?
| | Leukocyte Disorders | 1 | 2019 | 10 | 0.040 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 2019 | 26 | 0.040 |
Why?
| | Glycosylation | 2 | 1998 | 151 | 0.040 |
Why?
| | Rheology | 1 | 2020 | 92 | 0.040 |
Why?
| | Fetal Diseases | 1 | 1981 | 173 | 0.040 |
Why?
| | Proteins | 3 | 2005 | 1009 | 0.040 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2019 | 31 | 0.040 |
Why?
| | Prenatal Diagnosis | 1 | 1981 | 201 | 0.040 |
Why?
| | Insulin | 1 | 2010 | 2409 | 0.040 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2003 | 434 | 0.040 |
Why?
| | Neutrophil Activation | 1 | 2019 | 80 | 0.040 |
Why?
| | Fibroblasts | 2 | 2002 | 996 | 0.040 |
Why?
| | Immune System Diseases | 1 | 2019 | 39 | 0.040 |
Why?
| | Proto-Oncogene Proteins | 1 | 2003 | 648 | 0.040 |
Why?
| | Carcinoma | 2 | 1995 | 240 | 0.040 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 1999 | 16 | 0.040 |
Why?
| | Autocrine Communication | 1 | 1999 | 41 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 437 | 0.040 |
Why?
| | Calcium-Binding Proteins | 1 | 2020 | 218 | 0.040 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 1999 | 48 | 0.040 |
Why?
| | Pain | 2 | 1993 | 756 | 0.040 |
Why?
| | Vanadates | 1 | 1998 | 14 | 0.040 |
Why?
| | Genes, p53 | 1 | 1998 | 72 | 0.040 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1999 | 155 | 0.040 |
Why?
| | Epitopes | 3 | 1990 | 479 | 0.040 |
Why?
| | Mucin-2 | 1 | 2017 | 3 | 0.040 |
Why?
| | Adenosine | 1 | 2019 | 225 | 0.040 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1998 | 143 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 1998 | 83 | 0.040 |
Why?
| | Cell Adhesion | 3 | 2014 | 466 | 0.040 |
Why?
| | Biocompatible Materials | 1 | 2022 | 425 | 0.030 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2018 | 39 | 0.030 |
Why?
| | Ki-67 Antigen | 1 | 2018 | 112 | 0.030 |
Why?
| | Phosphoproteins | 1 | 2000 | 338 | 0.030 |
Why?
| | Aged, 80 and over | 3 | 2007 | 7635 | 0.030 |
Why?
| | Neutralization Tests | 3 | 1995 | 75 | 0.030 |
Why?
| | Binding, Competitive | 3 | 1996 | 202 | 0.030 |
Why?
| | Light | 1 | 2020 | 381 | 0.030 |
Why?
| | Receptor, Angiotensin, Type 1 | 2 | 2008 | 25 | 0.030 |
Why?
| | Dipeptides | 2 | 2008 | 50 | 0.030 |
Why?
| | In Vitro Techniques | 3 | 2006 | 1092 | 0.030 |
Why?
| | Neuregulins | 1 | 2017 | 7 | 0.030 |
Why?
| | Extracellular Space | 1 | 1997 | 119 | 0.030 |
Why?
| | Predictive Value of Tests | 3 | 2007 | 2031 | 0.030 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2017 | 72 | 0.030 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 1997 | 77 | 0.030 |
Why?
| | Graft Rejection | 1 | 2000 | 624 | 0.030 |
Why?
| | Prostaglandins | 1 | 1997 | 97 | 0.030 |
Why?
| | Hypertrophy | 2 | 2008 | 133 | 0.030 |
Why?
| | Transcription, Genetic | 4 | 2000 | 1457 | 0.030 |
Why?
| | Tumor Burden | 1 | 2018 | 309 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2008 | 5472 | 0.030 |
Why?
| | Models, Biological | 2 | 2020 | 1783 | 0.030 |
Why?
| | Spleen | 2 | 2010 | 514 | 0.030 |
Why?
| | Foreign Bodies | 1 | 1997 | 104 | 0.030 |
Why?
| | COS Cells | 2 | 2007 | 188 | 0.030 |
Why?
| | Survival Rate | 1 | 2021 | 1972 | 0.030 |
Why?
| | Mice, Inbred DBA | 2 | 1994 | 200 | 0.030 |
Why?
| | CHO Cells | 2 | 2007 | 161 | 0.030 |
Why?
| | Neoplasm Invasiveness | 2 | 2007 | 510 | 0.030 |
Why?
| | Catheterization, Central Venous | 1 | 1997 | 112 | 0.030 |
Why?
| | Cricetinae | 2 | 2007 | 289 | 0.030 |
Why?
| | Uterus | 1 | 1977 | 215 | 0.030 |
Why?
| | Cyclophosphamide | 2 | 2006 | 247 | 0.030 |
Why?
| | Adaptation, Physiological | 1 | 2019 | 553 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 658 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2008 | 5778 | 0.030 |
Why?
| | Fluorouracil | 2 | 2006 | 208 | 0.030 |
Why?
| | Transforming Growth Factor beta | 2 | 1995 | 480 | 0.030 |
Why?
| | Immunoblotting | 2 | 2008 | 308 | 0.030 |
Why?
| | Repressor Proteins | 1 | 1998 | 427 | 0.030 |
Why?
| | Caco-2 Cells | 3 | 1999 | 77 | 0.030 |
Why?
| | Genes, Dominant | 2 | 2006 | 96 | 0.030 |
Why?
| | Cerebral Angiography | 1 | 1975 | 109 | 0.030 |
Why?
| | Receptors, Growth Factor | 1 | 1994 | 55 | 0.030 |
Why?
| | Wiskott-Aldrich Syndrome Protein Family | 1 | 2014 | 3 | 0.030 |
Why?
| | 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase | 1 | 2014 | 5 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 4 | 2003 | 2486 | 0.030 |
Why?
| | Receptors, Fibroblast Growth Factor | 1 | 1994 | 67 | 0.030 |
Why?
| | Myelin Proteins | 1 | 2014 | 45 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2000 | 1091 | 0.030 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2014 | 14 | 0.030 |
Why?
| | Heart Transplantation | 1 | 2000 | 754 | 0.030 |
Why?
| | Carcinoma in Situ | 1 | 2014 | 49 | 0.030 |
Why?
| | Proteoglycans | 1 | 2014 | 107 | 0.030 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 1994 | 68 | 0.030 |
Why?
| | Demyelinating Diseases | 1 | 2014 | 85 | 0.030 |
Why?
| | Age Factors | 3 | 2009 | 3295 | 0.030 |
Why?
| | Lidocaine | 1 | 1993 | 42 | 0.030 |
Why?
| | Gene Expression | 2 | 1998 | 1502 | 0.030 |
Why?
| | Radiology, Interventional | 1 | 1993 | 33 | 0.030 |
Why?
| | Liver Regeneration | 1 | 1993 | 46 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 1994 | 172 | 0.030 |
Why?
| | Mitogens | 1 | 1993 | 61 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 1993 | 157 | 0.030 |
Why?
| | Adenoviridae | 2 | 2005 | 193 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-vav | 1 | 2013 | 2 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 1994 | 534 | 0.030 |
Why?
| | Metallothionein | 1 | 1992 | 25 | 0.030 |
Why?
| | Stomach Diseases | 1 | 1992 | 20 | 0.020 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2012 | 29 | 0.020 |
Why?
| | Menstrual Cycle | 1 | 1993 | 133 | 0.020 |
Why?
| | Risk Factors | 4 | 2010 | 10388 | 0.020 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 2003 | 150 | 0.020 |
Why?
| | Keratins | 1 | 1993 | 173 | 0.020 |
Why?
| | Antigens | 1 | 2014 | 357 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2013 | 283 | 0.020 |
Why?
| | Mammary Tumor Virus, Mouse | 1 | 1992 | 44 | 0.020 |
Why?
| | Polymerase Chain Reaction | 2 | 2010 | 1062 | 0.020 |
Why?
| | Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2011 | 6 | 0.020 |
Why?
| | Retroviridae | 2 | 2005 | 97 | 0.020 |
Why?
| | Contrast Media | 1 | 1975 | 467 | 0.020 |
Why?
| | Pregnancy Complications | 1 | 1977 | 527 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2013 | 139 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2015 | 789 | 0.020 |
Why?
| | Preoperative Care | 1 | 1993 | 362 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 134 | 0.020 |
Why?
| | Genes, BRCA2 | 1 | 2010 | 31 | 0.020 |
Why?
| | Genes, BRCA1 | 1 | 2010 | 40 | 0.020 |
Why?
| | Hybridomas | 1 | 1990 | 237 | 0.020 |
Why?
| | Pregnancy | 3 | 1995 | 6763 | 0.020 |
Why?
| | Antibody Specificity | 1 | 1990 | 189 | 0.020 |
Why?
| | Homeodomain Proteins | 2 | 2007 | 506 | 0.020 |
Why?
| | Colony-Stimulating Factors | 1 | 1990 | 36 | 0.020 |
Why?
| | Receptors, CCR1 | 1 | 2010 | 4 | 0.020 |
Why?
| | Preoperative Period | 1 | 2010 | 129 | 0.020 |
Why?
| | Body Fluids | 1 | 2010 | 66 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 697 | 0.020 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 243 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 144 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2005 | 430 | 0.020 |
Why?
| | Gene Amplification | 1 | 2010 | 104 | 0.020 |
Why?
| | SEER Program | 1 | 2010 | 227 | 0.020 |
Why?
| | Bone Marrow Cells | 1 | 1990 | 316 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 1987 | 345 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2010 | 179 | 0.020 |
Why?
| | Bone Marrow | 1 | 1990 | 286 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2012 | 433 | 0.020 |
Why?
| | bcl-2-Associated X Protein | 1 | 2009 | 56 | 0.020 |
Why?
| | Alabama | 1 | 1988 | 33 | 0.020 |
Why?
| | Helicobacter pylori | 1 | 2009 | 42 | 0.020 |
Why?
| | Recombination, Genetic | 1 | 2010 | 204 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2000 | 385 | 0.020 |
Why?
| | Exons | 1 | 2010 | 355 | 0.020 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2010 | 177 | 0.020 |
Why?
| | Tyrphostins | 1 | 2008 | 18 | 0.020 |
Why?
| | DNA | 4 | 1999 | 1459 | 0.020 |
Why?
| | Tissue Array Analysis | 1 | 2008 | 57 | 0.020 |
Why?
| | Intracellular Membranes | 1 | 2008 | 84 | 0.020 |
Why?
| | GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2008 | 20 | 0.020 |
Why?
| | Caspase 3 | 1 | 2009 | 246 | 0.020 |
Why?
| | Exocytosis | 1 | 2008 | 89 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 233 | 0.020 |
Why?
| | Axilla | 1 | 2007 | 47 | 0.020 |
Why?
| | Skin Neoplasms | 1 | 1995 | 855 | 0.020 |
Why?
| | Proteomics | 1 | 2014 | 1111 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2008 | 92 | 0.020 |
Why?
| | Mice, Inbred BALB C | 3 | 1995 | 1272 | 0.020 |
Why?
| | Premenopause | 1 | 2007 | 131 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1250 | 0.020 |
Why?
| | Cricetulus | 1 | 2007 | 109 | 0.020 |
Why?
| | Calcimycin | 1 | 2006 | 49 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 1994 | 940 | 0.020 |
Why?
| | Fibronectins | 1 | 1987 | 133 | 0.020 |
Why?
| | Fixatives | 1 | 1986 | 15 | 0.020 |
Why?
| | Growth and Development | 1 | 2006 | 7 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2008 | 404 | 0.020 |
Why?
| | Histocytochemistry | 1 | 1986 | 80 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2006 | 117 | 0.020 |
Why?
| | Lymphatic Metastasis | 1 | 2007 | 352 | 0.020 |
Why?
| | Artifacts | 1 | 2006 | 129 | 0.020 |
Why?
| | Antigens, Surface | 1 | 1986 | 154 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2006 | 132 | 0.020 |
Why?
| | Binding Sites | 2 | 2005 | 1303 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2007 | 286 | 0.020 |
Why?
| | Organ Specificity | 1 | 1986 | 305 | 0.010 |
Why?
| | Ionophores | 1 | 2005 | 24 | 0.010 |
Why?
| | Oligonucleotides | 1 | 2006 | 148 | 0.010 |
Why?
| | Lac Operon | 1 | 2005 | 44 | 0.010 |
Why?
| | Phantoms, Imaging | 1 | 2006 | 152 | 0.010 |
Why?
| | Guanylate Kinases | 1 | 2005 | 13 | 0.010 |
Why?
| | Specimen Handling | 1 | 2006 | 183 | 0.010 |
Why?
| | Type C Phospholipases | 1 | 2005 | 74 | 0.010 |
Why?
| | Rabbits | 1 | 2006 | 794 | 0.010 |
Why?
| | Two-Hybrid System Techniques | 1 | 2005 | 59 | 0.010 |
Why?
| | Aorta | 1 | 2008 | 417 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2006 | 431 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2003 | 2057 | 0.010 |
Why?
| | Liver | 1 | 1993 | 1943 | 0.010 |
Why?
| | Guinea Pigs | 2 | 1996 | 158 | 0.010 |
Why?
| | Alkaline Phosphatase | 1 | 2005 | 148 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2014 | 5131 | 0.010 |
Why?
| | Chemokine CXCL6 | 1 | 2004 | 2 | 0.010 |
Why?
| | Chemokine CXCL16 | 1 | 2004 | 4 | 0.010 |
Why?
| | Receptors, Scavenger | 1 | 2004 | 23 | 0.010 |
Why?
| | Culture Media, Conditioned | 2 | 1995 | 110 | 0.010 |
Why?
| | Macrophages, Peritoneal | 1 | 2004 | 94 | 0.010 |
Why?
| | Cytodiagnosis | 1 | 2003 | 33 | 0.010 |
Why?
| | Acetophenones | 1 | 2003 | 13 | 0.010 |
Why?
| | Neoadjuvant Therapy | 1 | 2006 | 404 | 0.010 |
Why?
| | RNA | 1 | 2010 | 921 | 0.010 |
Why?
| | Janus Kinase 2 | 1 | 2003 | 32 | 0.010 |
Why?
| | Catalysis | 1 | 2004 | 307 | 0.010 |
Why?
| | Benzopyrans | 1 | 2003 | 26 | 0.010 |
Why?
| | Radioimmunoassay | 2 | 1993 | 173 | 0.010 |
Why?
| | Hematopoietic Stem Cells | 1 | 1986 | 406 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2004 | 319 | 0.010 |
Why?
| | Reactive Oxygen Species | 1 | 2005 | 622 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2005 | 665 | 0.010 |
Why?
| | Cranial Fossa, Posterior | 1 | 1981 | 18 | 0.010 |
Why?
| | Chemokine CX3CL1 | 1 | 2001 | 24 | 0.010 |
Why?
| | Fetus | 1 | 1986 | 806 | 0.010 |
Why?
| | RNA, Small Interfering | 1 | 2004 | 622 | 0.010 |
Why?
| | B7-2 Antigen | 1 | 2000 | 27 | 0.010 |
Why?
| | Mice, Inbred A | 1 | 2000 | 49 | 0.010 |
Why?
| | Immune Sera | 1 | 2000 | 88 | 0.010 |
Why?
| | Antibodies, Blocking | 1 | 2000 | 33 | 0.010 |
Why?
| | CD28 Antigens | 1 | 2000 | 53 | 0.010 |
Why?
| | Injections, Intraperitoneal | 1 | 2000 | 114 | 0.010 |
Why?
| | B7-1 Antigen | 1 | 2000 | 58 | 0.010 |
Why?
| | CD40 Ligand | 1 | 2000 | 41 | 0.010 |
Why?
| | Histocompatibility Testing | 1 | 2000 | 126 | 0.010 |
Why?
| | Lymphopenia | 1 | 2000 | 62 | 0.010 |
Why?
| | Injections, Intravenous | 1 | 2000 | 206 | 0.010 |
Why?
| | Receptor Cross-Talk | 1 | 2000 | 21 | 0.010 |
Why?
| | Oncogene Protein v-crk | 1 | 2000 | 1 | 0.010 |
Why?
| | Retinoblastoma-Like Protein p130 | 1 | 2000 | 4 | 0.010 |
Why?
| | Genes, src | 1 | 2000 | 5 | 0.010 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2000 | 162 | 0.010 |
Why?
| | Crk-Associated Substrate Protein | 1 | 2000 | 4 | 0.010 |
Why?
| | src Homology Domains | 1 | 2000 | 41 | 0.010 |
Why?
| | Retinoblastoma Protein | 1 | 2000 | 57 | 0.010 |
Why?
| | Costs and Cost Analysis | 1 | 2001 | 213 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2000 | 283 | 0.010 |
Why?
| | Transplantation, Homologous | 1 | 2000 | 416 | 0.010 |
Why?
| | Epidermis | 1 | 2000 | 157 | 0.010 |
Why?
| | Cytoskeletal Proteins | 1 | 2000 | 158 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2000 | 343 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme Inhibitors | 1 | 1999 | 10 | 0.010 |
Why?
| | Pharmacokinetics | 1 | 1999 | 29 | 0.010 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2000 | 203 | 0.010 |
Why?
| | Drug Resistance, Multiple | 1 | 1999 | 25 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2006 | 1774 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 2003 | 1060 | 0.010 |
Why?
| | Ribonucleases | 1 | 1999 | 55 | 0.010 |
Why?
| | Carcinogenicity Tests | 1 | 1998 | 10 | 0.010 |
Why?
| | CCN Intercellular Signaling Proteins | 1 | 1998 | 5 | 0.010 |
Why?
| | Protein Binding | 1 | 2005 | 2224 | 0.010 |
Why?
| | Thiocarbamates | 1 | 1998 | 6 | 0.010 |
Why?
| | Genes, Viral | 1 | 1998 | 88 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 1998 | 82 | 0.010 |
Why?
| | Rodentia | 1 | 1998 | 57 | 0.010 |
Why?
| | Cytochrome P-450 CYP3A | 1 | 1999 | 88 | 0.010 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 1999 | 83 | 0.010 |
Why?
| | Arsenicals | 1 | 1998 | 30 | 0.010 |
Why?
| | Coronary Disease | 1 | 2000 | 385 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1999 | 372 | 0.010 |
Why?
| | Pyrrolidines | 1 | 1998 | 79 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2000 | 500 | 0.010 |
Why?
| | Polyethylene Terephthalates | 1 | 1997 | 11 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 1990 | 597 | 0.010 |
Why?
| | Surface Properties | 1 | 1999 | 413 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2001 | 1178 | 0.010 |
Why?
| | DNA Replication | 1 | 1999 | 238 | 0.010 |
Why?
| | Pregnancy, Multiple | 1 | 1977 | 17 | 0.010 |
Why?
| | Foreign-Body Reaction | 1 | 1997 | 31 | 0.010 |
Why?
| | Polyhydramnios | 1 | 1977 | 17 | 0.010 |
Why?
| | Nitrobenzenes | 1 | 1997 | 13 | 0.010 |
Why?
| | Sulindac | 1 | 1997 | 16 | 0.010 |
Why?
| | Cyclooxygenase 2 Inhibitors | 1 | 1997 | 21 | 0.010 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 1998 | 172 | 0.010 |
Why?
| | Cell Compartmentation | 1 | 1997 | 52 | 0.010 |
Why?
| | Catheters, Indwelling | 1 | 1997 | 91 | 0.010 |
Why?
| | RNA, Neoplasm | 1 | 1997 | 82 | 0.010 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 1997 | 79 | 0.010 |
Why?
| | Cyclooxygenase 2 | 1 | 1997 | 178 | 0.010 |
Why?
| | Pyelonephritis | 1 | 1975 | 10 | 0.010 |
Why?
| | Xanthomatosis | 1 | 1975 | 9 | 0.010 |
Why?
| | Aging | 2 | 1998 | 1864 | 0.010 |
Why?
| | Diatrizoate | 1 | 1975 | 2 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1996 | 332 | 0.010 |
Why?
| | Cell Cycle | 1 | 1998 | 601 | 0.010 |
Why?
| | Adolescent | 2 | 2010 | 21513 | 0.010 |
Why?
| | Caseins | 1 | 1995 | 20 | 0.010 |
Why?
| | Iothalamic Acid | 1 | 1975 | 5 | 0.010 |
Why?
| | Subtraction Technique | 1 | 1975 | 23 | 0.010 |
Why?
| | Papilloma | 1 | 1995 | 52 | 0.010 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 1994 | 15 | 0.010 |
Why?
| | Fibroblast Growth Factor 1 | 1 | 1994 | 13 | 0.010 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 1994 | 23 | 0.010 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 1994 | 27 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1994 | 201 | 0.010 |
Why?
| | Integrins | 1 | 1995 | 95 | 0.010 |
Why?
| | Drosophila | 1 | 1996 | 154 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1996 | 560 | 0.010 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 1994 | 87 | 0.010 |
Why?
| | Chronic Disease | 1 | 2000 | 1793 | 0.010 |
Why?
| | 9,10-Dimethyl-1,2-benzanthracene | 1 | 1994 | 24 | 0.010 |
Why?
| | Radiography, Interventional | 1 | 1995 | 116 | 0.010 |
Why?
| | Head | 1 | 1975 | 105 | 0.010 |
Why?
| | Lactation | 1 | 1995 | 181 | 0.010 |
Why?
| | Blood Physiological Phenomena | 1 | 1993 | 13 | 0.010 |
Why?
| | Radioligand Assay | 1 | 1993 | 48 | 0.010 |
Why?
| | Culture Media, Serum-Free | 1 | 1993 | 48 | 0.010 |
Why?
| | Thymidine | 1 | 1993 | 60 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 1993 | 127 | 0.010 |
Why?
| | Carotid Arteries | 1 | 1975 | 206 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 1993 | 171 | 0.010 |
Why?
| | Pyrazoles | 1 | 1997 | 423 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2000 | 1502 | 0.010 |
Why?
| | Biological Factors | 1 | 1993 | 39 | 0.010 |
Why?
| | Sulfonamides | 1 | 1997 | 513 | 0.010 |
Why?
| | Movement | 1 | 1975 | 278 | 0.010 |
Why?
| | Cell Count | 1 | 1993 | 324 | 0.010 |
Why?
| | Gastric Juice | 1 | 1992 | 6 | 0.010 |
Why?
| | Hydrochloric Acid | 1 | 1992 | 9 | 0.010 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1992 | 28 | 0.010 |
Why?
| | Insulin-Like Growth Factor I | 1 | 1994 | 319 | 0.010 |
Why?
| | Isoquinolines | 1 | 1992 | 43 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1994 | 844 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1992 | 362 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 1992 | 190 | 0.010 |
Why?
| | Hepatectomy | 1 | 1993 | 251 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1992 | 443 | 0.010 |
Why?
| | Child | 1 | 2010 | 21935 | 0.010 |
Why?
| | Phytohemagglutinins | 1 | 1990 | 30 | 0.010 |
Why?
| | Receptors, Colony-Stimulating Factor | 1 | 1990 | 7 | 0.010 |
Why?
| | Colony-Forming Units Assay | 1 | 1990 | 91 | 0.010 |
Why?
| | Chromatography, Affinity | 1 | 1990 | 88 | 0.010 |
Why?
| | Trypsin | 1 | 1990 | 77 | 0.010 |
Why?
| | Piperazines | 1 | 1992 | 350 | 0.010 |
Why?
| | Culture Media | 1 | 1990 | 165 | 0.000 |
Why?
| | Endopeptidases | 1 | 1990 | 90 | 0.000 |
Why?
| | Biological Assay | 1 | 1990 | 124 | 0.000 |
Why?
| | Disulfides | 1 | 1990 | 107 | 0.000 |
Why?
| | Superoxides | 1 | 1990 | 202 | 0.000 |
Why?
| | Adenine Nucleotides | 1 | 1968 | 23 | 0.000 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 1968 | 54 | 0.000 |
Why?
| | Myocardium | 1 | 1968 | 1002 | 0.000 |
Why?
| | Renal Artery | 1 | 1975 | 37 | 0.000 |
Why?
| | Biopsy | 1 | 1975 | 1129 | 0.000 |
Why?
| | Tritium | 1 | 1968 | 76 | 0.000 |
Why?
| | Denervation | 1 | 1968 | 24 | 0.000 |
Why?
| | Adenylyl Cyclases | 1 | 1968 | 87 | 0.000 |
Why?
| | Cats | 1 | 1968 | 210 | 0.000 |
Why?
| | Cyclic AMP | 1 | 1968 | 234 | 0.000 |
Why?
|
|
Dempsey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|